First Patient in US Treated with Elekta's Leksell Gamma Knife Icon

Medical Device Investing

Elekta announced that its Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery (SRS) system currently available, was used for the first time in the US on March 1 at Sutter Medical Center, Sacramento Gamma Knife Center to treat a metastatic brain tumor.

Elekta announced that its Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery (SRS) system currently available, was used for the first time in the US on March 1 at Sutter Medical Center, Sacramento Gamma Knife Center to treat a metastatic brain tumor.
According to the news:

The patient, a 52-year-old male, from El Dorado Hills, Calif., had previously undergone successful treatment for primary melanoma and for melanoma metastases to his lung. The patient’s treatment was planned and guided using a frameless approach. The frameless mask solution is one of several new features of Icon and is integrated with a novel high definition motion management.  The system provides accuracy similar to that of frame-based SRS systems while minimizing dose to normal tissue.

Samuel Ciricillo, MD, Medical Director of Adult and Pediatric Neurosurgery at Sutter Neuroscience Institute commented:

Increasing the precision of frameless cranial SRS is essential for effectively targeting tumor tissue while protecting healthy brain tissue from damage. The new Gamma Knife system, Icon, now provides the most accurate motion tracking during treatment. Additionally, with Gamma Knife there is a two- to four-fold improvement in sparing normal brain tissue compared to other linear accelerator platforms. These features allow for greater potential to protect patient quality of life both during treatment and after recovery.

Click here to view the news. 

The Conversation (0)
×